Osimertinib activates a TGF-β2-dependent secretory program that drives lung adenocarcinoma progression.
奥希替尼激活TGF-β2依赖性分泌程序,从而驱动肺腺癌进展。
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI198418
Ghosh Madhurima, Wu Chao, Kumar Abhishek, Nilsson Monique, Heymach John V, Zhao Weina, Yu Jiang, Liu Xin, Ding Na, Wang Shike, Xiao Guan-Yu, Chen Angelo, Grimley Kate, Russell William K, Creighton Chad J, Tan Xiaochao, Kurie Jonathan M